Oxygen-independent regulation of HIF-1α through PI3K/AKT and rapamycin has also been shown to occur in breast cancer cells upon treatment with the ErbB3/ErbB4 ligand heregulin, which stimulates HIF-1α synthesis and VEGF-A expression [174]. This evidence concerns the gene HIF1A and breast carcinoma.